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Cervicoisthmic choriocarcinoma mimicking 
cesarean section scar ectopic pregnancy
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Primary choriocarcinoma of the uterine cervix is an extremely rare disease. The clinical diagnosis of cervical choriocarcinoma is 
difficult, because of its rarity and being non-specific abnormal vaginal bleeding the most common symptom. In the present report, 
the authors present a case of cervical choriocarcinoma, which was initially misdiagnosed as a cesarean section scar ectopic pregnancy. 
Remission of cervical choriocarcinoma was accomplished with the combination of hysterectomy and chemotherapy.
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section (C-section) at 40 and 39 gestational week 
respectively. Her second and last pregnancy ended 
in the first trimester abortion in 2007 and 2010 
respectively.
After 17 weeks of amenorrhea, serum beta human 
chorionic gonadotropin (β-hCG) was 40796 mUI/ml. 
Trans-vaginal ultrasound scan failed to identify an 
intrauterine pregnancy and showed the presence of 
an extremely vascularized cervical mass, localized 
in the isthmic region of the cervix, just over the scar 
of the previous C-section. The patient was considered 
to have an ectopic cesarean scar pregnancy and then 
was referred to our clinic, Careggi University Hospital 
as a third level hospital, for a better diagnostic and 
therapeutically assessment.
We repeated trans-vaginal ultrasound scan that 
confirmed the diagnosis [Figures 1 and 2]. Serum 
β-hCG level continued to grow reaching the value of 
60,000 mUI/dl in 3 days. The patient had no any other 
symptoms than little vaginal bleeding.
Since, there is no standard protocol in the treatment of 
cesarean scar pregnancy, we discussed with the patient 
three treatment options: Expectant management, 
medical therapy or conservative surgical therapy. The 
decision fell on surgery and the patient underwent 
explorative laparotomy. The cervical lesion appeared as 
a large, friable highly vascularized mass that occupied 
INTRODUCTION
Primary gestational cervical choriocarcinoma is an 
extremely rare disease and belongs to heterogeneous 
family of the gestational trophoblastic disease (GTD). 
Gestational choriocarcinoma is associated with 
co-incident or antecedent pregnancy. These pregnancies 
may be normal term pregnancy, molar pregnancy or 
abortion.
There are nearly 90 extra-uterine choriocarcinoma cases 
in the literature and uterine cervix is the most common 
site.[1]
The clinical diagnosis of cervical choriocarcinoma is 
difficult, because of its rarity and being non-specific 
abnormal vaginal bleeding the most common symptom.
In the present report, the authors present a case of 
cervical choriocarcinoma misdiagnosed as ectopic 
pregnancy.
CASE REPORT
In August 2012, a 30-year-old Chinese woman was 
admitted to Pescia Hospital for irregular vaginal 
bleeding of 10 days duration and sovrapubic pain.
She was gravida 4 para 2. Her first and third 
pregnancy ended in full term delivery by cesarean 
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the whole thickness of cervical wall. Intra-operative 
conversion to hysterectomy became necessary since the 
unfeasibility of conservative uterine surgery. The patient 
made an uneventful recovery. She was discharged on 
postoperative day 4, with serum β-hCG of 4885 mUI/ml.
Definitive pathologic evaluation of surgical specimen 
led to the diagnosis of: Primary gestational cervical 
choriocarcinoma with the presence of syncitiotrophoblastic 
and cytotrophoblast ic  cel ls  [Figures 3  and 4] . 
Imunohistochemical staining was positive for β-hCG.
No metastases were detected by post-surgical whole-body 
computed tomography (CT).
The FIGO (Fédération Internationale de Gynécologie et 
d’Obstétrique) 2000 criteria showed a stage I choriocarcinoma 
(confined to the uterus) with a FIGO score of 8:[2] Abortion 
before choriocarcinoma (1 point), delay between pregnancy 
and choriocarcinoma of over 12 months (4 points), and 
β-hCG blood level of between 10,000 and 100,000 (2 points), 
largest tumor size of 3, 7 cm (1 point).
According to the FIGO classification, the patient began a 
combination chemotherapy using etoposide, methotrexate, 
actinomycin D, alternating with cyclophosphamide and 
oncovine (EMA-CO).
After the first cycle of chemotherapy, the serum β-hCG 
decreased to normal range (<5 mUI/dl). Eight weeks after 
the β-hCG level was still negative and treatment ended with 
the third cycle of EMA-CO.
One month later whole body CT scan revealed no abnormality.
DISCUSSION
In women, choriocarcinoma usually arises in the uterine 
cavity. Extra-uterine choriocarcinoma is an extremely rare 
condition, found mostly in the cervix.
Figure 1: Ultrasound two-dimensional image of the cervix; the arrows outline 
the presence of the extra-uterine “mass”
Figure 2: Ultrasound color Doppler applied to the cervix, showing a highly 
vascularized zone
Figure 3: Tumor lesion in the lower left corner and cervical glandular cript in the 
upper right corner of the figure (H and E, ×40)
Figure 4: Choriocarcinoma. Atypical cytotrophoblasts and syncytiotrophoblasts 
with pronounced cytologic atypia (H and E, ×400)
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or any gestational sac well-defined. There was only a 
gestational tissue with high-density vascularization 
[Figures 1 and 2].
The imaging findings with the clinical signs and 
symptoms, and the rarity of choriocarcinoma misled us 
to the initial diagnosis of ectopic pregnancy. This resulted 
in delay in administrating appropriate chemotherapy 
with a subsequent hysterectomy, unnecessary in a young 
patient.
In the literature, the majority of the cases with 
choriocarcinoma were initially treated with hysterectomy 
due to incontrollable bleeding.[2] Recently, selective arterial 
embolization was used to control bleeding from cervical 
choriocarcinoma allowing successfully conservative 
management by chemotherapy alone.[7,8] The clinical 
presentation of our patient wasn’t a life-threatening vaginal 
bleeding and conservative management could have been 
proposed.
We believe focusing on epidemiologic risk factor of 
choriocarcinoma; diagnosis of choriocarcinoma could have 
been made early. Our patient was a Chinese woman with 
two previous abortions. In Italy the rate of choriocarcinoma 
is 0.013/1,000 pregnancies and 0.030/1,000 deliveries.[9] In 
Asia, Africa and Latin America, the incidence rates are 
higher, about 1 in 500-1000 pregnancies. Twenty-five percent 
of choriocarcinoma growth occurs following an abortion.
In conclusion, although its rarity, choriocarcinoma should 
be considered in the differential diagnosis of a patient 
with the classic symptoms and imaging findings of ectopic 
pregnancy, particularly in Asiatic patient with history of 
recurrent abortion. A large increase in the incidence of 
choriocarcinoma is expected as a result of immigration 
from Asian in recent decades and we should then consider 
choriocarcinoma in the differential diagnosis of irregular 
vaginal bleeding, positive β-hCG level, and absence of an 
embryo at ultrasound.
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